nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—ACY1—female reproductive system—ovarian cancer	0.009	0.0471	CbGeAlD
Acetylcysteine—CHUK—epithelium—ovarian cancer	0.00836	0.0437	CbGeAlD
Acetylcysteine—ACY1—testis—ovarian cancer	0.00726	0.038	CbGeAlD
Acetylcysteine—IKBKB—myometrium—ovarian cancer	0.00724	0.0379	CbGeAlD
Acetylcysteine—GSS—myometrium—ovarian cancer	0.00711	0.0372	CbGeAlD
Acetylcysteine—IKBKB—embryo—ovarian cancer	0.00696	0.0364	CbGeAlD
Acetylcysteine—CHUK—female reproductive system—ovarian cancer	0.00621	0.0325	CbGeAlD
Acetylcysteine—CHUK—female gonad—ovarian cancer	0.00565	0.0296	CbGeAlD
Acetylcysteine—IKBKB—uterine cervix—ovarian cancer	0.00563	0.0295	CbGeAlD
Acetylcysteine—GSS—uterine cervix—ovarian cancer	0.00553	0.0289	CbGeAlD
Acetylcysteine—IKBKB—decidua—ovarian cancer	0.00537	0.0281	CbGeAlD
Acetylcysteine—GSS—decidua—ovarian cancer	0.00527	0.0276	CbGeAlD
Acetylcysteine—GRIN2D—testis—ovarian cancer	0.00514	0.0269	CbGeAlD
Acetylcysteine—SLC7A11—female reproductive system—ovarian cancer	0.00511	0.0268	CbGeAlD
Acetylcysteine—IKBKB—endometrium—ovarian cancer	0.0051	0.0267	CbGeAlD
Acetylcysteine—CHUK—testis—ovarian cancer	0.00501	0.0262	CbGeAlD
Acetylcysteine—GSS—endometrium—ovarian cancer	0.005	0.0262	CbGeAlD
Acetylcysteine—GRIN3A—testis—ovarian cancer	0.00483	0.0253	CbGeAlD
Acetylcysteine—IKBKB—gonad—ovarian cancer	0.00473	0.0247	CbGeAlD
Acetylcysteine—IKBKB—uterus—ovarian cancer	0.0047	0.0246	CbGeAlD
Acetylcysteine—SLC7A11—female gonad—ovarian cancer	0.00465	0.0243	CbGeAlD
Acetylcysteine—GSS—gonad—ovarian cancer	0.00464	0.0243	CbGeAlD
Acetylcysteine—GSS—uterus—ovarian cancer	0.00461	0.0241	CbGeAlD
Acetylcysteine—GRIN2A—vagina—ovarian cancer	0.00428	0.0224	CbGeAlD
Acetylcysteine—IKBKB—female reproductive system—ovarian cancer	0.00422	0.0221	CbGeAlD
Acetylcysteine—GSS—female reproductive system—ovarian cancer	0.00414	0.0217	CbGeAlD
Acetylcysteine—SLC7A11—testis—ovarian cancer	0.00413	0.0216	CbGeAlD
Acetylcysteine—GSS—bone marrow—ovarian cancer	0.00391	0.0205	CbGeAlD
Acetylcysteine—IKBKB—female gonad—ovarian cancer	0.00384	0.0201	CbGeAlD
Acetylcysteine—GRIN2A—testis—ovarian cancer	0.00382	0.02	CbGeAlD
Acetylcysteine—IKBKB—vagina—ovarian cancer	0.00382	0.02	CbGeAlD
Acetylcysteine—GSS—female gonad—ovarian cancer	0.00377	0.0197	CbGeAlD
Acetylcysteine—GSS—vagina—ovarian cancer	0.00375	0.0196	CbGeAlD
Acetylcysteine—CHUK—lymph node—ovarian cancer	0.00363	0.019	CbGeAlD
Acetylcysteine—IKBKB—testis—ovarian cancer	0.00341	0.0178	CbGeAlD
Acetylcysteine—GSS—testis—ovarian cancer	0.00334	0.0175	CbGeAlD
Acetylcysteine—SLCO1B1—female reproductive system—ovarian cancer	0.00305	0.0159	CbGeAlD
Acetylcysteine—Dizziness—Altretamine—ovarian cancer	0.00277	0.0104	CcSEcCtD
Acetylcysteine—Vomiting—Altretamine—ovarian cancer	0.00267	0.00998	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Paclitaxel—ovarian cancer	0.00264	0.00989	CcSEcCtD
Acetylcysteine—Nausea—Altretamine—ovarian cancer	0.00249	0.00933	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—ovarian cancer	0.00247	0.0129	CbGeAlD
Acetylcysteine—GSS—lymph node—ovarian cancer	0.00242	0.0127	CbGeAlD
Acetylcysteine—Chest discomfort—Paclitaxel—ovarian cancer	0.00242	0.00905	CcSEcCtD
Acetylcysteine—Thinking abnormal—Paclitaxel—ovarian cancer	0.00234	0.00875	CcSEcCtD
Acetylcysteine—Body temperature increased—Carboplatin—ovarian cancer	0.00229	0.00858	CcSEcCtD
Acetylcysteine—Stomatitis—Chlorambucil—ovarian cancer	0.00228	0.00853	CcSEcCtD
Acetylcysteine—Bronchospasm—Melphalan—ovarian cancer	0.00225	0.00841	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Docetaxel—ovarian cancer	0.00224	0.00838	CcSEcCtD
Acetylcysteine—Gait disturbance—Paclitaxel—ovarian cancer	0.00219	0.00821	CcSEcCtD
Acetylcysteine—Wheezing—Paclitaxel—ovarian cancer	0.00208	0.00778	CcSEcCtD
Acetylcysteine—Chest discomfort—Docetaxel—ovarian cancer	0.00205	0.00767	CcSEcCtD
Acetylcysteine—Stomatitis—Topotecan—ovarian cancer	0.00203	0.00759	CcSEcCtD
Acetylcysteine—Sweating—Topotecan—ovarian cancer	0.00199	0.00747	CcSEcCtD
Acetylcysteine—Stomatitis—Melphalan—ovarian cancer	0.00198	0.00743	CcSEcCtD
Acetylcysteine—Bronchospasm—Vinorelbine—ovarian cancer	0.00196	0.00735	CcSEcCtD
Acetylcysteine—Mental disability—Paclitaxel—ovarian cancer	0.00186	0.00695	CcSEcCtD
Acetylcysteine—Pharyngitis—Topotecan—ovarian cancer	0.00185	0.00694	CcSEcCtD
Acetylcysteine—Ear pain—Paclitaxel—ovarian cancer	0.00182	0.00682	CcSEcCtD
Acetylcysteine—Stomatitis—Vinorelbine—ovarian cancer	0.00173	0.00649	CcSEcCtD
Acetylcysteine—Eye pain—Paclitaxel—ovarian cancer	0.00172	0.00644	CcSEcCtD
Acetylcysteine—Flushing—Melphalan—ovarian cancer	0.0017	0.00635	CcSEcCtD
Acetylcysteine—Angiopathy—Topotecan—ovarian cancer	0.00169	0.00634	CcSEcCtD
Acetylcysteine—Immune system disorder—Topotecan—ovarian cancer	0.00169	0.00632	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Topotecan—ovarian cancer	0.00168	0.0063	CcSEcCtD
Acetylcysteine—Angioedema—Chlorambucil—ovarian cancer	0.00167	0.00625	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—ovarian cancer	0.00165	0.00619	CcSEcCtD
Acetylcysteine—Immune system disorder—Melphalan—ovarian cancer	0.00165	0.00618	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Melphalan—ovarian cancer	0.00165	0.00617	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—ovarian cancer	0.00156	0.00584	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—ovarian cancer	0.00153	0.00573	CcSEcCtD
Acetylcysteine—Angioedema—Topotecan—ovarian cancer	0.00148	0.00556	CcSEcCtD
Acetylcysteine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00148	0.00555	CcSEcCtD
Acetylcysteine—Flushing—Vinorelbine—ovarian cancer	0.00148	0.00555	CcSEcCtD
Acetylcysteine—Angiopathy—Vinorelbine—ovarian cancer	0.00145	0.00543	CcSEcCtD
Acetylcysteine—Immune system disorder—Vinorelbine—ovarian cancer	0.00144	0.0054	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—ovarian cancer	0.00144	0.0054	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00144	0.00539	CcSEcCtD
Acetylcysteine—Cough—Topotecan—ovarian cancer	0.00142	0.00531	CcSEcCtD
Acetylcysteine—Erythema—Vinorelbine—ovarian cancer	0.00139	0.00521	CcSEcCtD
Acetylcysteine—Cough—Melphalan—ovarian cancer	0.00139	0.0052	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00139	0.0052	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00137	0.00515	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00135	0.00504	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—ovarian cancer	0.00134	0.005	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Topotecan—ovarian cancer	0.00133	0.00497	CcSEcCtD
Acetylcysteine—Dyspepsia—Chlorambucil—ovarian cancer	0.00131	0.00491	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Melphalan—ovarian cancer	0.0013	0.00486	CcSEcCtD
Acetylcysteine—Oedema—Melphalan—ovarian cancer	0.0013	0.00486	CcSEcCtD
Acetylcysteine—Skin disorder—Topotecan—ovarian cancer	0.00129	0.00482	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00129	0.00482	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Topotecan—ovarian cancer	0.00128	0.0048	CcSEcCtD
Acetylcysteine—Angioedema—Vinorelbine—ovarian cancer	0.00127	0.00476	CcSEcCtD
Acetylcysteine—Tachycardia—Melphalan—ovarian cancer	0.00127	0.00475	CcSEcCtD
Acetylcysteine—Skin disorder—Melphalan—ovarian cancer	0.00126	0.00472	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—ovarian cancer	0.00125	0.00469	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—ovarian cancer	0.00124	0.00463	CcSEcCtD
Acetylcysteine—Hypotension—Melphalan—ovarian cancer	0.00121	0.00454	CcSEcCtD
Acetylcysteine—Cough—Vinorelbine—ovarian cancer	0.00121	0.00454	CcSEcCtD
Acetylcysteine—Urticaria—Chlorambucil—ovarian cancer	0.00118	0.00443	CcSEcCtD
Acetylcysteine—Dyspnoea—Topotecan—ovarian cancer	0.00118	0.00443	CcSEcCtD
Acetylcysteine—Body temperature increased—Chlorambucil—ovarian cancer	0.00118	0.00441	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Docetaxel—ovarian cancer	0.00118	0.00441	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00118	0.0044	CcSEcCtD
Acetylcysteine—Dyspepsia—Topotecan—ovarian cancer	0.00117	0.00437	CcSEcCtD
Acetylcysteine—Stomatitis—Paclitaxel—ovarian cancer	0.00117	0.00437	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—ovarian cancer	0.00116	0.00434	CcSEcCtD
Acetylcysteine—Dyspnoea—Melphalan—ovarian cancer	0.00116	0.00434	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00115	0.00429	CcSEcCtD
Acetylcysteine—Dyspepsia—Melphalan—ovarian cancer	0.00114	0.00428	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00113	0.00425	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00112	0.0042	CcSEcCtD
Acetylcysteine—Bronchospasm—Docetaxel—ovarian cancer	0.00112	0.00419	CcSEcCtD
Acetylcysteine—Tachycardia—Vinorelbine—ovarian cancer	0.00111	0.00415	CcSEcCtD
Acetylcysteine—Skin disorder—Vinorelbine—ovarian cancer	0.0011	0.00413	CcSEcCtD
Acetylcysteine—Hypersensitivity—Chlorambucil—ovarian cancer	0.0011	0.00411	CcSEcCtD
Acetylcysteine—Pharyngitis—Paclitaxel—ovarian cancer	0.00107	0.00399	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—ovarian cancer	0.00106	0.00397	CcSEcCtD
Acetylcysteine—Hypotension—Vinorelbine—ovarian cancer	0.00106	0.00397	CcSEcCtD
Acetylcysteine—Pruritus—Chlorambucil—ovarian cancer	0.00105	0.00395	CcSEcCtD
Acetylcysteine—Urticaria—Topotecan—ovarian cancer	0.00105	0.00395	CcSEcCtD
Acetylcysteine—Body temperature increased—Topotecan—ovarian cancer	0.00105	0.00393	CcSEcCtD
Acetylcysteine—Urticaria—Melphalan—ovarian cancer	0.00103	0.00386	CcSEcCtD
Acetylcysteine—Dyspnoea—Vinorelbine—ovarian cancer	0.00101	0.00379	CcSEcCtD
Acetylcysteine—Flushing—Paclitaxel—ovarian cancer	0.000997	0.00373	CcSEcCtD
Acetylcysteine—Cardiac disorder—Paclitaxel—ovarian cancer	0.000997	0.00373	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—ovarian cancer	0.000989	0.0037	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—ovarian cancer	0.000983	0.00368	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—ovarian cancer	0.000982	0.00368	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00098	0.00367	CcSEcCtD
Acetylcysteine—Hypersensitivity—Topotecan—ovarian cancer	0.000977	0.00366	CcSEcCtD
Acetylcysteine—Angiopathy—Paclitaxel—ovarian cancer	0.000975	0.00365	CcSEcCtD
Acetylcysteine—Immune system disorder—Paclitaxel—ovarian cancer	0.00097	0.00363	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000968	0.00363	CcSEcCtD
Acetylcysteine—Hypersensitivity—Melphalan—ovarian cancer	0.000957	0.00358	CcSEcCtD
Acetylcysteine—Vomiting—Chlorambucil—ovarian cancer	0.000947	0.00355	CcSEcCtD
Acetylcysteine—Pruritus—Topotecan—ovarian cancer	0.000938	0.00351	CcSEcCtD
Acetylcysteine—Erythema—Paclitaxel—ovarian cancer	0.000935	0.0035	CcSEcCtD
Acetylcysteine—Pruritus—Melphalan—ovarian cancer	0.000919	0.00344	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000917	0.00343	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—ovarian cancer	0.00091	0.00341	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—ovarian cancer	0.000904	0.00338	CcSEcCtD
Acetylcysteine—Urticaria—Vinorelbine—ovarian cancer	0.000901	0.00338	CcSEcCtD
Acetylcysteine—Body temperature increased—Vinorelbine—ovarian cancer	0.000897	0.00336	CcSEcCtD
Acetylcysteine—Nausea—Chlorambucil—ovarian cancer	0.000885	0.00331	CcSEcCtD
Acetylcysteine—Dizziness—Topotecan—ovarian cancer	0.000877	0.00328	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—ovarian cancer	0.000857	0.00321	CcSEcCtD
Acetylcysteine—Angioedema—Paclitaxel—ovarian cancer	0.000854	0.0032	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000849	0.00318	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—ovarian cancer	0.000845	0.00316	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—ovarian cancer	0.000845	0.00316	CcSEcCtD
Acetylcysteine—Vomiting—Topotecan—ovarian cancer	0.000843	0.00316	CcSEcCtD
Acetylcysteine—Syncope—Paclitaxel—ovarian cancer	0.000839	0.00314	CcSEcCtD
Acetylcysteine—Rash—Topotecan—ovarian cancer	0.000836	0.00313	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000836	0.00313	CcSEcCtD
Acetylcysteine—Dermatitis—Topotecan—ovarian cancer	0.000835	0.00313	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—ovarian cancer	0.000826	0.00309	CcSEcCtD
Acetylcysteine—Vomiting—Melphalan—ovarian cancer	0.000826	0.00309	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—ovarian cancer	0.000822	0.00308	CcSEcCtD
Acetylcysteine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000822	0.00308	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000821	0.00307	CcSEcCtD
Acetylcysteine—Rash—Melphalan—ovarian cancer	0.000819	0.00307	CcSEcCtD
Acetylcysteine—Dermatitis—Melphalan—ovarian cancer	0.000818	0.00306	CcSEcCtD
Acetylcysteine—Cough—Paclitaxel—ovarian cancer	0.000816	0.00306	CcSEcCtD
Acetylcysteine—Pruritus—Vinorelbine—ovarian cancer	0.000803	0.00301	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000794	0.00297	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—ovarian cancer	0.000793	0.00297	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—ovarian cancer	0.000793	0.00297	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000791	0.00296	CcSEcCtD
Acetylcysteine—Nausea—Topotecan—ovarian cancer	0.000788	0.00295	CcSEcCtD
Acetylcysteine—Nausea—Melphalan—ovarian cancer	0.000771	0.00289	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—ovarian cancer	0.000767	0.00287	CcSEcCtD
Acetylcysteine—Oedema—Paclitaxel—ovarian cancer	0.000763	0.00286	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000763	0.00286	CcSEcCtD
Acetylcysteine—Shock—Paclitaxel—ovarian cancer	0.000751	0.00281	CcSEcCtD
Acetylcysteine—Dizziness—Vinorelbine—ovarian cancer	0.00075	0.00281	CcSEcCtD
Acetylcysteine—Tachycardia—Paclitaxel—ovarian cancer	0.000745	0.00279	CcSEcCtD
Acetylcysteine—Skin disorder—Paclitaxel—ovarian cancer	0.000741	0.00278	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000738	0.00276	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000734	0.00275	CcSEcCtD
Acetylcysteine—Vomiting—Vinorelbine—ovarian cancer	0.000721	0.0027	CcSEcCtD
Acetylcysteine—Rash—Vinorelbine—ovarian cancer	0.000715	0.00268	CcSEcCtD
Acetylcysteine—Dermatitis—Vinorelbine—ovarian cancer	0.000715	0.00268	CcSEcCtD
Acetylcysteine—Hypotension—Paclitaxel—ovarian cancer	0.000713	0.00267	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—ovarian cancer	0.000711	0.00266	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—ovarian cancer	0.00071	0.00266	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—ovarian cancer	0.000697	0.00261	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—ovarian cancer	0.000692	0.00259	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—ovarian cancer	0.000684	0.00256	CcSEcCtD
Acetylcysteine—Dyspnoea—Paclitaxel—ovarian cancer	0.00068	0.00255	CcSEcCtD
Acetylcysteine—Somnolence—Paclitaxel—ovarian cancer	0.000678	0.00254	CcSEcCtD
Acetylcysteine—Nausea—Vinorelbine—ovarian cancer	0.000674	0.00252	CcSEcCtD
Acetylcysteine—Dyspepsia—Paclitaxel—ovarian cancer	0.000672	0.00252	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00067	0.00251	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—ovarian cancer	0.000667	0.0025	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000659	0.00247	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—ovarian cancer	0.000656	0.00246	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000647	0.00242	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—ovarian cancer	0.000647	0.00242	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—ovarian cancer	0.000636	0.00238	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—ovarian cancer	0.000633	0.00237	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—ovarian cancer	0.000631	0.00236	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—ovarian cancer	0.000628	0.00235	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—ovarian cancer	0.000617	0.00231	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—ovarian cancer	0.000609	0.00228	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—ovarian cancer	0.000607	0.00227	CcSEcCtD
Acetylcysteine—Urticaria—Paclitaxel—ovarian cancer	0.000606	0.00227	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—ovarian cancer	0.000604	0.00226	CcSEcCtD
Acetylcysteine—Body temperature increased—Paclitaxel—ovarian cancer	0.000603	0.00226	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—ovarian cancer	0.000577	0.00216	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—ovarian cancer	0.000575	0.00215	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—ovarian cancer	0.00057	0.00213	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—ovarian cancer	0.00057	0.00213	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—ovarian cancer	0.000569	0.00213	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—ovarian cancer	0.000564	0.00211	CcSEcCtD
Acetylcysteine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000562	0.00211	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000558	0.00209	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—ovarian cancer	0.000557	0.00209	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—ovarian cancer	0.000555	0.00208	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000553	0.00207	CcSEcCtD
Acetylcysteine—Pruritus—Paclitaxel—ovarian cancer	0.00054	0.00202	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—ovarian cancer	0.000535	0.002	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—ovarian cancer	0.000527	0.00197	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000527	0.00197	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—ovarian cancer	0.000516	0.00193	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—ovarian cancer	0.000513	0.00192	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000512	0.00192	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—ovarian cancer	0.000511	0.00192	CcSEcCtD
Acetylcysteine—Dizziness—Paclitaxel—ovarian cancer	0.000505	0.00189	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—ovarian cancer	0.000495	0.00185	CcSEcCtD
Acetylcysteine—Vomiting—Paclitaxel—ovarian cancer	0.000485	0.00182	CcSEcCtD
Acetylcysteine—Rash—Paclitaxel—ovarian cancer	0.000481	0.0018	CcSEcCtD
Acetylcysteine—Dermatitis—Paclitaxel—ovarian cancer	0.000481	0.0018	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—ovarian cancer	0.000479	0.0018	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—ovarian cancer	0.000477	0.00178	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—ovarian cancer	0.00047	0.00176	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—ovarian cancer	0.000466	0.00175	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—ovarian cancer	0.000458	0.00171	CcSEcCtD
Acetylcysteine—Nausea—Paclitaxel—ovarian cancer	0.000453	0.0017	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000452	0.00169	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—ovarian cancer	0.000444	0.00166	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000436	0.00163	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—ovarian cancer	0.000436	0.00163	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000435	0.00163	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—ovarian cancer	0.000432	0.00162	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—ovarian cancer	0.000429	0.00161	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—ovarian cancer	0.000428	0.0016	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—ovarian cancer	0.000426	0.00159	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—ovarian cancer	0.000424	0.00159	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000422	0.00158	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000418	0.00157	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—ovarian cancer	0.000411	0.00154	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—ovarian cancer	0.000408	0.00153	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—ovarian cancer	0.000408	0.00153	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—ovarian cancer	0.000407	0.00153	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—ovarian cancer	0.000404	0.00151	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000404	0.00151	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—ovarian cancer	0.000397	0.00149	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—ovarian cancer	0.000394	0.00148	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—ovarian cancer	0.000392	0.00147	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00039	0.00146	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—ovarian cancer	0.000389	0.00146	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—ovarian cancer	0.000388	0.00145	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—ovarian cancer	0.000384	0.00144	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—ovarian cancer	0.000384	0.00144	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—ovarian cancer	0.000377	0.00141	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000377	0.00141	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—ovarian cancer	0.00036	0.00135	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—ovarian cancer	0.000359	0.00134	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—ovarian cancer	0.000355	0.00133	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000349	0.00131	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—ovarian cancer	0.000347	0.0013	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—ovarian cancer	0.000345	0.00129	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—ovarian cancer	0.000321	0.0012	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—ovarian cancer	0.000321	0.0012	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—ovarian cancer	0.000319	0.0012	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—ovarian cancer	0.000309	0.00116	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000297	0.00111	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—ovarian cancer	0.000289	0.00108	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—ovarian cancer	0.000286	0.00107	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—ovarian cancer	0.000277	0.00104	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—ovarian cancer	0.000275	0.00103	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—ovarian cancer	0.000275	0.00103	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—ovarian cancer	0.000267	0.001	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—ovarian cancer	0.000259	0.000971	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—ovarian cancer	0.000257	0.000961	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—ovarian cancer	0.000255	0.000953	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—ovarian cancer	0.000254	0.000952	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—ovarian cancer	0.00024	0.000898	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by NGF—MAPK1—ovarian cancer	6.1e-05	0.000113	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—ovarian cancer	6.1e-05	0.000113	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—YAP1—ovarian cancer	6.09e-05	0.000112	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—ovarian cancer	6.07e-05	0.000112	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.05e-05	0.000112	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CD—ovarian cancer	6.02e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—XIAP—ovarian cancer	5.97e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—ovarian cancer	5.94e-05	0.00011	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—ovarian cancer	5.92e-05	0.000109	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—ovarian cancer	5.88e-05	0.000109	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—ovarian cancer	5.88e-05	0.000108	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—ovarian cancer	5.86e-05	0.000108	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—ovarian cancer	5.86e-05	0.000108	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—ovarian cancer	5.84e-05	0.000108	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMARCA4—ovarian cancer	5.82e-05	0.000107	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—ovarian cancer	5.76e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PPP2R1A—ovarian cancer	5.73e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—ovarian cancer	5.71e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CD—ovarian cancer	5.68e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EREG—ovarian cancer	5.68e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PPP2R1A—ovarian cancer	5.63e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ERBB2—ovarian cancer	5.54e-05	0.000102	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—ovarian cancer	5.53e-05	0.000102	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—YAP1—ovarian cancer	5.52e-05	0.000102	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—ovarian cancer	5.49e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CB—ovarian cancer	5.46e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MTOR—ovarian cancer	5.46e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CD—ovarian cancer	5.46e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—XIAP—ovarian cancer	5.41e-05	9.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—ovarian cancer	5.4e-05	9.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—ovarian cancer	5.39e-05	9.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PGR—ovarian cancer	5.32e-05	9.82e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.32e-05	9.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ERBB2—ovarian cancer	5.32e-05	9.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—ovarian cancer	5.29e-05	9.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMARCA4—ovarian cancer	5.27e-05	9.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—ovarian cancer	5.26e-05	9.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CB—ovarian cancer	5.25e-05	9.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MTOR—ovarian cancer	5.25e-05	9.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—ovarian cancer	5.17e-05	9.54e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—ovarian cancer	5.16e-05	9.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EREG—ovarian cancer	5.15e-05	9.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1B—ovarian cancer	5.13e-05	9.46e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—ovarian cancer	5.03e-05	9.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ERBB2—ovarian cancer	5.02e-05	9.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—ovarian cancer	5.01e-05	9.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—ovarian cancer	4.98e-05	9.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—FASN—ovarian cancer	4.98e-05	9.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CB—ovarian cancer	4.95e-05	9.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MTOR—ovarian cancer	4.95e-05	9.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PARP1—ovarian cancer	4.95e-05	9.13e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—ovarian cancer	4.94e-05	9.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1B—ovarian cancer	4.92e-05	9.09e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	4.9e-05	9.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—ovarian cancer	4.9e-05	9.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—ovarian cancer	4.84e-05	8.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PGR—ovarian cancer	4.82e-05	8.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ERBB2—ovarian cancer	4.82e-05	8.9e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—ovarian cancer	4.81e-05	8.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—ovarian cancer	4.77e-05	8.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—ovarian cancer	4.77e-05	8.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CB—ovarian cancer	4.76e-05	8.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MTOR—ovarian cancer	4.76e-05	8.78e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	4.73e-05	8.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—ovarian cancer	4.72e-05	8.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—ovarian cancer	4.69e-05	8.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1B—ovarian cancer	4.65e-05	8.58e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.63e-05	8.55e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—ovarian cancer	4.55e-05	8.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—ovarian cancer	4.55e-05	8.4e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	4.54e-05	8.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—ovarian cancer	4.53e-05	8.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TLR4—ovarian cancer	4.51e-05	8.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PARP1—ovarian cancer	4.48e-05	8.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1B—ovarian cancer	4.46e-05	8.24e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—ovarian cancer	4.44e-05	8.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—ovarian cancer	4.39e-05	8.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—ovarian cancer	4.33e-05	7.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6ST—ovarian cancer	4.32e-05	7.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—ovarian cancer	4.28e-05	7.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—ovarian cancer	4.21e-05	7.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CAV1—ovarian cancer	4.21e-05	7.77e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—ovarian cancer	4.14e-05	7.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—ovarian cancer	4.11e-05	7.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR4—ovarian cancer	4.09e-05	7.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—ovarian cancer	4.04e-05	7.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK3—ovarian cancer	4.03e-05	7.44e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	4.02e-05	7.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PPP2R1A—ovarian cancer	4.01e-05	7.4e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4e-05	7.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6ST—ovarian cancer	3.99e-05	7.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6ST—ovarian cancer	3.92e-05	7.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK1—ovarian cancer	3.84e-05	7.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—ovarian cancer	3.84e-05	7.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APC—ovarian cancer	3.83e-05	7.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—ovarian cancer	3.82e-05	7.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—ovarian cancer	3.82e-05	7.05e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCB1—ovarian cancer	3.74e-05	6.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—ovarian cancer	3.68e-05	6.8e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—ovarian cancer	3.67e-05	6.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—ovarian cancer	3.67e-05	6.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK3—ovarian cancer	3.66e-05	6.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—ovarian cancer	3.65e-05	6.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PPP2R1A—ovarian cancer	3.64e-05	6.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—ovarian cancer	3.63e-05	6.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—ovarian cancer	3.48e-05	6.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK1—ovarian cancer	3.48e-05	6.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—ovarian cancer	3.48e-05	6.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—ovarian cancer	3.47e-05	6.4e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—ovarian cancer	3.38e-05	6.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—ovarian cancer	3.37e-05	6.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—ovarian cancer	3.34e-05	6.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—ovarian cancer	3.33e-05	6.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—ovarian cancer	3.31e-05	6.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—ovarian cancer	3.29e-05	6.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—ovarian cancer	3.22e-05	5.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—ovarian cancer	3.2e-05	5.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—ovarian cancer	3.19e-05	5.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—ovarian cancer	3.18e-05	5.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—ovarian cancer	3.18e-05	5.87e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—ovarian cancer	3.16e-05	5.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—ovarian cancer	3.08e-05	5.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—ovarian cancer	3.02e-05	5.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—ovarian cancer	2.99e-05	5.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—ovarian cancer	2.98e-05	5.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—ovarian cancer	2.96e-05	5.46e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAV1—ovarian cancer	2.96e-05	5.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—ovarian cancer	2.95e-05	5.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CAV1—ovarian cancer	2.95e-05	5.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—ovarian cancer	2.94e-05	5.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—ovarian cancer	2.94e-05	5.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—ovarian cancer	2.92e-05	5.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—ovarian cancer	2.92e-05	5.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—ovarian cancer	2.9e-05	5.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—ovarian cancer	2.89e-05	5.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—ovarian cancer	2.89e-05	5.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—ovarian cancer	2.89e-05	5.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—ovarian cancer	2.84e-05	5.24e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.82e-05	5.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—ovarian cancer	2.82e-05	5.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6ST—ovarian cancer	2.79e-05	5.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—ovarian cancer	2.79e-05	5.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—ovarian cancer	2.76e-05	5.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—ovarian cancer	2.75e-05	5.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—ovarian cancer	2.72e-05	5.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—ovarian cancer	2.71e-05	5e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	2.69e-05	4.97e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—ovarian cancer	2.68e-05	4.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—ovarian cancer	2.68e-05	4.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—ovarian cancer	2.68e-05	4.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—ovarian cancer	2.67e-05	4.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CAV1—ovarian cancer	2.67e-05	4.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—ovarian cancer	2.65e-05	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—ovarian cancer	2.61e-05	4.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—ovarian cancer	2.6e-05	4.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—ovarian cancer	2.58e-05	4.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—ovarian cancer	2.56e-05	4.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—ovarian cancer	2.54e-05	4.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6ST—ovarian cancer	2.53e-05	4.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—ovarian cancer	2.49e-05	4.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—ovarian cancer	2.47e-05	4.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—ovarian cancer	2.46e-05	4.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—ovarian cancer	2.45e-05	4.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—ovarian cancer	2.43e-05	4.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—ovarian cancer	2.43e-05	4.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—ovarian cancer	2.37e-05	4.37e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	2.37e-05	4.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—ovarian cancer	2.36e-05	4.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—ovarian cancer	2.35e-05	4.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—ovarian cancer	2.27e-05	4.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—ovarian cancer	2.26e-05	4.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK1—ovarian cancer	2.24e-05	4.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—ovarian cancer	2.24e-05	4.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—ovarian cancer	2.23e-05	4.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—ovarian cancer	2.22e-05	4.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—ovarian cancer	2.17e-05	4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—ovarian cancer	2.14e-05	3.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—ovarian cancer	2.13e-05	3.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—ovarian cancer	2.11e-05	3.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—ovarian cancer	2.11e-05	3.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—ovarian cancer	2.08e-05	3.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK1—ovarian cancer	2.06e-05	3.81e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	2.06e-05	3.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—ovarian cancer	2.06e-05	3.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—ovarian cancer	2.06e-05	3.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—ovarian cancer	2.06e-05	3.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK1—ovarian cancer	2.03e-05	3.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—ovarian cancer	2.03e-05	3.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—ovarian cancer	1.98e-05	3.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—ovarian cancer	1.95e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—ovarian cancer	1.94e-05	3.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—ovarian cancer	1.93e-05	3.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—ovarian cancer	1.91e-05	3.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—ovarian cancer	1.89e-05	3.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—ovarian cancer	1.89e-05	3.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—ovarian cancer	1.89e-05	3.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—ovarian cancer	1.87e-05	3.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—ovarian cancer	1.87e-05	3.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—ovarian cancer	1.84e-05	3.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—ovarian cancer	1.82e-05	3.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—ovarian cancer	1.79e-05	3.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—ovarian cancer	1.79e-05	3.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—ovarian cancer	1.79e-05	3.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—ovarian cancer	1.79e-05	3.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—ovarian cancer	1.78e-05	3.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—ovarian cancer	1.78e-05	3.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—ovarian cancer	1.76e-05	3.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—ovarian cancer	1.75e-05	3.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—ovarian cancer	1.72e-05	3.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—ovarian cancer	1.72e-05	3.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—ovarian cancer	1.71e-05	3.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—ovarian cancer	1.67e-05	3.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—ovarian cancer	1.66e-05	3.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—ovarian cancer	1.65e-05	3.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—ovarian cancer	1.63e-05	3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—ovarian cancer	1.62e-05	2.99e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—ovarian cancer	1.61e-05	2.97e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—ovarian cancer	1.61e-05	2.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—ovarian cancer	1.59e-05	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—ovarian cancer	1.59e-05	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—ovarian cancer	1.59e-05	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—ovarian cancer	1.58e-05	2.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—ovarian cancer	1.56e-05	2.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—ovarian cancer	1.52e-05	2.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—ovarian cancer	1.48e-05	2.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—ovarian cancer	1.46e-05	2.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—ovarian cancer	1.46e-05	2.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK1—ovarian cancer	1.45e-05	2.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—ovarian cancer	1.45e-05	2.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—ovarian cancer	1.44e-05	2.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—ovarian cancer	1.44e-05	2.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—ovarian cancer	1.44e-05	2.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—ovarian cancer	1.38e-05	2.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—ovarian cancer	1.37e-05	2.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—ovarian cancer	1.34e-05	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK1—ovarian cancer	1.31e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—ovarian cancer	1.31e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.26e-05	2.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—ovarian cancer	1.25e-05	2.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—ovarian cancer	1.24e-05	2.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—ovarian cancer	1.21e-05	2.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—ovarian cancer	1.16e-05	2.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—ovarian cancer	1.14e-05	2.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—ovarian cancer	1.11e-05	2.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—ovarian cancer	1.1e-05	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—ovarian cancer	1.05e-05	1.94e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.03e-05	1.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—ovarian cancer	1.02e-05	1.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—ovarian cancer	1.01e-05	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—ovarian cancer	9.29e-06	1.71e-05	CbGpPWpGaD
